Objective: Rheumatoid arthritis (RA) is a chronic, disabling disease that can greatly compromise health-related quality of life (HRQoL). The aim of this study was to assess the impact of a 6-week twice/week Iyengar yoga program on HRQoL of young adults with RA compared with a usual-care waitlist control group.
R heumatoid arthritis (RA) is a chronic autoimmune disorder that can impact joint function and healthrelated quality of life (HRQoL), especially when arthritis develops early in a person's life. 1, 2 Health care use, depression, and pain are high among adolescents and young adults with arthritis, even compared with young people with other chronic conditions. 1 The maintenance of emotional and physical functioning is important in this group. Pain and debilitated functioning may leave many young people with RA in a socially and emotionally compromised state 3 with difficulties persisting into later adulthood. Because young patients may encounter exceptional difficulties dealing with their illness, interventions targeting young adults are warranted.
Despite the need for physical and psychological treatments aimed at young people with RA, traditional approaches remain limited. 4 A multipronged treatment strategy is recommended, including rehabilitation efforts that promote a range of physical outcomes such as ambulation and balance. 5 Patients who exercise regularly report decreased pain and improved functioning. 6 Iyengar yoga (IY) may be suited for meeting the rehabilitation needs of people with RA. The tradition has evolved specific methods of teaching therapeutic yoga practices to people with health problems. [7] [8] [9] These methods include a focus on correct anatomic alignment, thought to protect joints, and the use of supportive props designed to relieve tension and inflammation in the body. Poses can also be individualized for each patient, a method that is an important concern for RA patients given that affected bodily areas and progression of the disease can vary markedly among individuals. Focus on the body, including alignment of the posture and fluctuating bodily sensations, and the breath provides meditative benefits. The rigorous, systematized teacher training support IY's use within the medical and research fields. 10 Yoga has led to a number of positive changes in individuals with musculoskeletal problems with few safety concerns. [11] [12] [13] Previous literature has demonstrated the promise of yoga for older people with RA; however, the utility of yoga for younger populations is unknown. With the exception of our recent single-arm, early pilot work examining of IY for pain and functioning in young adults with RA, 14 there have been no studies focused specifically on young patients. Despite being limited by a small sample size, our feasibility study showed a high level of acceptance of IY among young people with RA and significant reductions in pain, pain disability, depression, mental health, vitality, and self-efficacy following the 6-week course of yoga. Attendance was high (mean = 95%) and no adverse events were reported. The strength of patient's quantitative and qualitative reports of improvement led us to conduct the current study, using an exploratory randomized usual-care waitlist control design.
The first aim of the current study was to compare the impact of our 6-week IY intervention on the primary outcomes of HRQoL including pain and disability and the secondary outcomes of pain intensity, disease activity, and psychological functioning to that of a usual-care waitlist control group. To test the clinical significance of the program, patients' global improvement compared with baseline was also examined. The second aim was to examine treatment effects and maintenance of treatment gains on all participants who received the IY intervention (ie, combining the immediate and waitlisted yoga groups) on the primary outcomes and data from a weekly monitoring report of pain, anxiety, depression, and sleep before, during, and after treatment.
METHODS

Study Design
Upon entry, participants were randomized to receive either immediate IY (the yoga group) or the usual-care waitlist group (control group). The control group received IY after the completion of the waitlist period. Thus, participants in the yoga group were assessed at 3 time points: 
Inclusion Criteria
The inclusion criteria for the current study included diagnosis of RA for at least 6 months according to the revised 1987 American College of Rheumatology criteria or juvenile idiopathic arthritis for at least 6 months, aged between 16 and 35 years; concomitant use of diseasemodifying antirheumatic medications, nonsteroidal antiinflammatory drugs, or low-dose corticosteroids permitted provided doses were stable for 4 weeks; and ability to provide written informed consent and ability to speak and understand English. Participants were excluded if they were currently pregnant, recently experienced injury, had a history of drug or alcohol abuse, or had been on any experimental medications in the preceding 6 months. Full approval for this study was received from the University of California, Los Angeles Institutional Review Board.
Treatment Conditions
IY Program
The intervention was based on the protocol we developed in our previous pilot study 14 and consisted of 6 weeks of classes held twice per week. The classes were 1.5 hours in duration (total dose = 18 h). A make-up class was available at the end of the program. Classes had a maximum of 7 students, lead by an experienced IY teacher (B.S.) and assisted by at least 1 junior teacher. To standardize delivery, a working list of poses (Table 1) was developed with a senior IY teacher, who served as an advisor to the study. Classes were held in the University of California, Los Angeles Pediatric Pain Program Yoga Studio, which is equipped with standard IY equipment, including ropes fastened securely to the walls, blankets, bolsters, and blocks.
A full range of yoga postures were taught to the students, including supine poses, passive backbends, standing poses, supported inversions, twists, seated postures, and forward bends. The postures were taught with props. The classes were sequenced over time and as students developed skills, more challenging postures were introduced. Individual limitations were addressed as needed for pain, range of motion in particular joints, and fatigue. For example, 3 students had severe limitations in the mobility of the joints in their hips, knees, shoulders, and wrists that prevented them from getting up and down off the floor. Rather than using the floor as a base, as is typically the case during supine and seated postures, we raised the floor by using several chairs for support. In another example of the range of modifications that were used, students who could not bend their knees hung from the wall ropes in a modified straight-legged version of rope headstand. In cases where students had shoulder, elbow, and wrist problems, supine poses were performed with supportive blankets under their arms. Classes were held during a weekday evening and on a weekend afternoon to ensure that employed participants and full-time students had access to classes. Homework was suggested, but not required, and interested participants were invited to take props home for the duration of the intervention.
Usual-Care Waitlisted Control Group
This condition controlled for the effects of routine care of patients treated for RA. It is not uncommon in psychological or behavioral research contexts to include a waitlist condition in early stages of the clinical trial process. Given that a gold standard in control groups has yet to be set in yoga research, we opted for a usual-care waitlist condition at this early stage of testing the intervention. Control participants were contacted weekly by a research assistant who administered a Weekly Monitoring Form (WMF). Upon completion of the waitlist period, the control group was offered yoga.
Participants
Seventy-three participants were originally screened for study eligibility. Thirty patients were willing to participate and were randomized to either the yoga or waitlist control group ( Fig. 1 ). Of the 73 participants who were assessed for eligibility, 21 were excluded based upon eligibility criteria. An additional 22 declined to participate, with the most common reason cited being conflicts with or being too busy to commit to yoga classes. Thus, 30 participants were randomized into the groups. Attrition was <15%. Of the 30 participants who were randomized and completed baseline assessments, 4 dropped out (3 in the yoga group, 1 in the waitlist group). These participants were lost early in the study, for example, 1 participant in the yoga group completed the baseline assessments but did not attend any yoga classes. There were no significant age or disease characteristic differences between those who dropped out of the study and those who completed. The randomized controlled trial results are based on the 26 participants who completed baseline and postassessments (yoga = 11; control = 15). After being offered yoga, 2 waitlist participants dropped out. Results based on the maintenance of treatment benefits are based on the 24 yoga completers. All participants were female.
Participants received a diagnosis of RA by a rheumatologist. At the baseline medical assessment and at the end of the intervention, a Disease Activity Scale (DAS28) joint examination was performed by a physician blind to group assignment. After the joint count evaluation, the DAS28 score was calculated by including the sedimentation rate and the general health assessment rated by the evaluating physician using a visual analogue scale. At the baseline exam, the mean DAS28 score was 4.5 (SD = 1.9) and at postintervention, the mean DAS28 score was 3.3 (SD = 1.4). The scores did not differ by group. Seven participants reported comorbid chronic conditions, with the most common (n = 5) being lupus. Other comorbid conditions reported were connective tissue disorder, osteoarthritis, and epilepsy. Of the 26 study completers, 21 reported taking at least 1 disease-modifying antirheumatic drug at baseline assessments. Seven reported taking nonsteroidal anti-inflammatory drugs, and 5 reported regularly taking prednisone. Both groups had similar medication profiles and there were no significant differences between the groups in disease-modifying antirheumatic drug use. Additional demographic and clinical information for participants are presented in Table 2 .
Recruitment and Assessment
Recruitment for the study occurred between August 2009 and January 2011, with recruitment continuing during yoga class cohorts. The primary recruitment strategy included advertisements in rheumatology offices and local community bulletin boards, arthritis support group newsletters and events, and through physician referrals of patients and online sources (eg, Craigslist, the Clinical Trials.gov website). Participants who lived >25 miles away from the yoga studio where classes were administered were offered $10 each session attended to cover gas expenses.
Eligibility was determined during a phone screening session with a research assistant and interested patients were informed that they would be randomized into either a yoga or a waitlist group. Before the baseline assessment, patients were randomized in blocks. Principal investigators were blinded to participant randomization during the study process.
Participants were scheduled for a baseline assessment approximately 2 weeks before the start of yoga classes. All eligible participants were e-mailed a link to complete a battery of questionnaires (detailed below) at the baseline, upon completion of the yoga intervention, and at 2-month follow-up. In addition, weekly functioning data were collected from participants. The WMFs were administered once a week for 2 weeks preceding the start of the intervention to determine baseline functioning, once a week throughout the duration of the intervention, and again at 2month follow-up. A link to an online version of the monitoring form was e-mailed weekly to participants and followed up with reminder e-mails to ensure timely completion.
Measures
HRQoL and Functioning
Short Form-36 (SF-36) 15 : was used to measure HRQoL. Four of the scales measuring well-being were used, including the vitality, bodily pain, general health, and mental health subscales. A higher score denotes increased quality of life, such that higher scores on the bodily pain scale denote less pain.
Pain Disability Index (PDI): measures pain-related functioning 16 and asks about ability to participate in basic life activities, including home responsibilities, recreation social activity, sexual behavior, self-care, and life-support activity. Patients rate their level of disability on a rating scale of 0 to 10. A higher score indicates more disability. Good internal reliability (a = 0.82) and validity have been reported. 16, 17 Health Assessment Questionnaire Disability Index (HAQ-DI): assesses arthritis-specific functioning, 18 including dressing, grooming, rising, eating, walking, and hygiene activities. The HAQ-DI also has a Global Scale, which asks about the patient's general health from 0 (very well) to 100 (very poor).
DAS28: is a combined index that measures disease activity in patients with RA. This index includes a physician performed 28 tender joint count, 28 swollen joint count, erythrocyte sedimentation rate, and general health assessment using a visual analogue scale.
Global Improvement Scale (GIS): This scale asks participants to rate their relative RA symptoms on a 7-point scale. The specific wording is as follows: "Compared to the way you felt before you entered the study, have your RA symptoms over the past 7 days been from 1 = substantially worse to 7 = substantially improved. 19 " Global improvement is noted for patients endorsing moderately or substantially improved status.
Psychological Functioning
Brief Symptom Inventory 20 : was used to measure mood and asks patients about their anxiety, somatization, and depressive symptoms in the past 7 days on a 5-point Likert scale ranging from "Not at all" to "Extremely." The Brief Symptom Inventory has shown good internal consistency and validity. 20 Higher scores denote more symptoms.
Functional Assessment of Chronic Illness Therapy Fatigue Subscale (FACIT-Fatigue) 21 : includes 13 items that assess physical and functional consequences of fatigue. Scores range from 0 to 52 on a reverse 4-point Likert scale, with higher scores indicating less fatigue.
Chronic Pain Acceptance Questionnaire 22 : measures the degree to which patients are willing to accept pain and move towards one's values even while experiencing pain. 23 This is a 20-item measure with acceptable reliability (a = 0.78 to 0.82) and validity. 22 Higher scores denote greater acceptance.
Five-Factor Mindfulness Questionnaire (FFMQ) 24, 25 : is a self-report 5-facet measure of mindfulness, which refers to the direction of attention to present moment experience. The 5 facets of mindfulness measured include Observe, Describe, Act with Awareness, Nonjudging, and Nonreactivity. Items are rated on a Likert scale ranging from 1 (never or very rarely true) to 5 (very often or always true). The FFMQ has been shown to have good internal consistency. Higher scores reflect greater mindfulness. Arthritis Self-efficacy Scale 26 : is designed to assess people with arthritis' beliefs that they can perform tasks or cope with the consequences of chronic arthritis. The scale has 20 items to measures 3 subscales: pain, function, and other symptoms. The pain scale can be combined with the other symptoms scale.
WMF: assessed participants' weekly worst pain, average pain, anxiety, depression, and trouble with sleep using a 0 to 10 numeric rating scale. For example, patients were asked to rate their worst pain over the past week from 0 (no pain) to 10 (worst pain imaginable); anxiety from 0 (no anxiety) to 10 (worst possible anxiety); depression from 0 (no depression) to 10 (worst possible depression); and difficulty staying asleep for the entire night from 0 (no difficulty) to 10 (very difficult). Participants were also asked to report any adverse events during the classes, any changes in medication, home practice of yoga, and level of physical activity.
Statistical Analyses
To ensure that randomization produced equivalent groups, t tests and w 2 tests compared the yoga and control groups on all demographic and baseline clinical variables. The data were analyzed for skewness and to ensure that data met assumptions for parametric tests. A minimum a-level of 0.05 was used for analyses.
Inferential analysis took place in 2 stages. We first conducted analysis of treatment effects in the controlled trial data (pretreatment to posttreatment in the yoga vs. waitlist groups on the primary and secondary outcomes). Posttreatment group effects were analyzed using analysis of covariance controlling for baseline scores. The groups' baseline scores on the individual outcome measures were included to ensure that baseline measure differences between the groups were accounted for. Any significant differences on disease characteristics between the groups were also included as covariates. Clinical significance was calculated for the 4 domains relevant to chronic pain trials as recommended by the Initiative on Methods, Measurement and Pain Assessment in Clinical Trials (IMMPACT): pain intensity, physical functioning, emotional functioning, and global improvement. 27 Using the IMMPACT recommendations regarding the clinical importance of treatment outcomes, 28 we calculated the clinical importance of the changes in the yoga group on these outcomes.
Second, we analyzed uncontrolled effects and treatment gains on a sample of all participants who began treatment (ie, yoga and waitlist groups combined, n = 24). We used postwaiting list assessments as pretreatment assessments for waiting list participants. Linear mixed models were performed to assess significant linear trends over time for the primary outcomes and for the weekly reports of pain, anxiety, depression, and sleep before, during, and after treatment. Tests evaluated differences from baseline to posttreatment and from baseline to 2-month follow-up to evaluate maintenance of treatment gains. Mixed models can handle missing data and do not require that such data points be excluded or estimated.
Random intercepts were included in the models with time as the independent factor. Separate analyses were conducted for each of the measures. Inferential statistics and modeling was accomplished with SPSS version 19.0.
RESULTS
Preliminary Analyses
Initial tests revealed 1 significant baseline difference between the yoga and control groups. As shown in Table 2 , the yoga group had experienced RA for significantly longer than the control group. The duration of RA for the yoga and control groups was 15.8 and 6.8 years, respectively. Duration of RA symptoms was therefore included as a covariate in all between-groups analyses. None of the other demographic and clinical variables were significantly different between groups.
Examination of the outcome measures for normality and skewness revealed that one of the yoga participants was a consistent outlier, scoring >2 SD below the mean on 6 of the postintervention outcome measures. This person was excluded from further analyses and the final analyses for the controlled trial are based on 10 yoga participants and 15 controls. The data met normality assumptions and analysis of covariances examining group differences at postintervention controlling for baseline scores and duration of RA were performed. The GIS was only assessed at posttreatment and thus duration of RA was the only covariate included for the analysis of this scale. Table 3 shows HRQoL, arthritis functioning, and psychological functioning variables at preassessment and postassessment by group. Results from analyses evaluating posttreatment group differences on the primary outcome measures of PDI, and 2 of the SF-36 subscales, namely general health and vitality, were significant favoring the yoga group. However, there were no group differences on the pain or mental health SF-36 subscales, the DAS28, or the HAQ-Disability score. The HAQ general health question did reveal a difference, with the yoga group reporting significant improvements in general well-being compared with the waitlist condition. Significant findings favoring the yoga group were seen for a number of the psychological secondary outcomes, including the FACIT-Fatigue scale, the BSI global severity scale, the Chronic Pain Acceptance Questionnaire, the nonjudging facet of mindfulness, and self-efficacy regarding pain. The yoga group also reported significantly greater global improvement of RA symptoms as assessed by the GIS compared with the waitlist controls.
Controlled Trial
Clinical Significance
The IMMPACT recommendations for clinically important differences in pain intensity use reduction in pain of 10% to 20% as minimally important, with >30% change reflecting moderate improvement and >50% reduction reflecting substantial improvement. For the SF-36 pain scale, 40% of the yoga group experienced substantial improvement, 10% moderate improvement, and 10% minimal improvement (40% remained unchanged) . Surprisingly, the control group experienced similar levels of improvement.
We used the IMMPACT gauge of one half of the SD of a mood scale 28 to determine the clinical significance of the functioning and psychological outcomes. The following functioning scales showed clinically significant improvement in the yoga group: SF-36 general health, vitality, and PDI. The following psychological outcomes were clinically improved: BSI somatization, BSI global severity, FACIT-Fatigue, FFMQ nonjudge, and Arthritis Self-efficacy Scale pain. As recommended by the IMMPACT guidelines, the percentage of patients reporting global improvement was also calculated. The percentage of patients reporting substantially worse to substantially improved symptoms compared with baseline functioning on the GIS are shown in Figure 2 . For the yoga group, no one reported a worsening of symptoms. A large majority of the yoga group reported improvement, from slight improvement (50%), moderate improvement (20%), to substantial improvement (20%). In accordance with guidelines, ratings above "slight improvement" were combined. In the yoga group, 40% reported clinically important levels of improvement. For the waitlist group, only 1 participant reported clinically important levels of improvement.
Uncontrolled Effects and Maintenance of Treatment Response
Means and SDs for the primary outcomes at pretreatment, posttreatment, and 2-month follow-up are presented in Table 4 for all participants who began treatment (ie, the yoga and waiting list groups combined). Figure 3 depicts the WMF data across baseline, treatment, and follow-up for both groups combined. Thus, the baseline refers to the 2 weeks preceding yoga, which occurred at the beginning of the study for the yoga group and after the waitlist period for the waitlist group, weeks 1 to 6 of the yoga intervention, and then 2 months after completion of yoga for both groups.
Mixed model tests of fixed effects revealed that over time, yoga led to significant improvements in the PDI (F 46 = 3.93, P = 0.03) with baseline scores significantly higher than postintervention (t 46 = À 2.51, P = 0.02) and 2-month follow-up (t 46 = À2.34, P = 0.02), indicating reductions in pain disability following yoga that were maintained at follow-up. There were no significant differences on the HAQ-DI (F 46 = 1.82, P = 0.17). Yoga led to significant improvement in 3 of the 4 quality of life subscales: SF-36 vitality (F 46 = 6.07; P = 0.01) such that postintervention scores were significantly improved from baseline (t 46 = 3.48, P = 0.00) but not at follow-up; SF-36 general health (F 46 = 10.96, P = 0.00), such that postintervention scores were significantly improved from baseline (t 46 = 4.06, P = 0.00) and maintained at 2-month follow-up (t 46 = 4.06, P = 0.00); and SF-36 mental health (F 46 = 4.43, P = 0.02) with postintervention scores significantly improved from baseline (t 46 = 2.95, P = 0.01) but not at follow-up (t 46 = 1.78, P = 0.08). Reductions in the SF-36 bodily pain subscale were not statistically significant (F 46 = 2.97, P = 0.06).
Mixed models tests revealed statistically significant time effects for a number of the weekly monitoring variables, including a decrease over time in worst pain (F 181 = 2.63; P = 0.01) that was significant from baseline to week 3 of the yoga intervention and maintained across the remainder of the intervention and at the 2-month follow-up. Significant improvement was revealed for anxiety ratings over time (F 181 = 4.39, P = 0.00) and for depression over time (F 181 = 3.29, P = 0.00), both of which saw significant improvements during week 2 of the yoga intervention that maintained across the intervention and at the 2-month follow-up. Decreases in average pain (F 181 = 1.83, P = 0.07) and sleep difficulties (F 181 = 1.59, P = 0.10) were not statistically significant.
Yoga Practice
Ten women reported practicing at home during the intervention; duration of home sessions ranged from 5 to 45 minutes and the number of times practiced at home ranged from one during the intervention to 27 sessions during the intervention (median = twice during the intervention). At the 2-month follow-up, 6 women still reported practicing yoga during the previous week, either in a formal class or at home (range, 1 to 3 sessions/wk for 13-to 45-min duration).
DISCUSSION
Compared with the usual-care waitlist condition, the yoga group displayed significantly greater improvement on the primary outcomes of pain disability and 2 of the HRQoL subscales (general health and vitality). There were no group differences on pain, arthritis disability, or disease activity. Many of the psychological outcomes including fatigue, mood, chronic pain acceptance, mindfulness, and self-efficacy were significantly improved in the yoga group. Of importance, the yoga group showed significantly greater global improvement compared with controls, with almost half of the yoga group reporting clinically meaningful improvement of symptoms. The clinical significance of outcomes following interventions is critical in evaluating efficacy. 28 Overall, our results indicate that although the IY intervention did not reduce measures of disease activity or pain, participants randomized to receiving yoga did report feeling better.
Findings regarding the maintenance of treatment effects are also of note. Combining the yoga and waitlist yoga groups in the analysis allowed for increased power to examine the impact of IY over time. The combined group (yoga and waitlisted yoga) showed improvement in functioning after treatment that maintained at follow-up for the primary outcomes of pain disability and HRQoL general health and for weekly ratings of worst pain, anxiety, and depression. Two of the HRQoL subscales, vitality and mental health, showed significant improvement postintervention-gains that were not maintained at follow-up. It is interesting that both the postintervention vitality and mental health HRQoL subscales reached normative values for healthy females. 15 The findings are consistent with our previous pilot work showing IY to be safe, feasible, and a promising adjunct therapy in improving the well-being of young patients with RA. This study expands these findings by including a randomized controlled design, a larger sample size, and a range of physical and psychological outcomes. The present findings indicate that yoga may be associated with improvements in a number of domains. It is unclear from our evidence that how long treatment effects are maintained; improvements in general health, pain disability, and weekly ratings of anxiety, depression, and worst pain were maintained at 2 months, whereas postintervention improvements in the SF-36 vitality and mental health subscales were not. The effects of continued and varied intensities of yoga practice on the maintenance of benefits are also unclear. Although one quarter of the participants reported engaging in some yoga at the 2-month follow-up, only 3 participants had taken a formal yoga class (range, 1 to 3 classes) during the follow-up period, which may not have been sufficient to continue improvements demonstrated during the intervention. Further studies are needed to elucidate these dose-related effects. The weekly monitoring data provide a window into the functioning of participants across the intervention. After the second week of classes, participants reported significant improvements in their mood, whereas their ratings of worst pain significantly improved after the third week of classes. These improvements were maintained compared with baseline across the intervention and at the 2-month follow-up. The benefits reported that postintervention (including pain disability and HRQoL) may have been partly because of these gradual improvements beginning early in treatment.
RA patients in their young adult years may be in particular need of complementary interventions that can be used alongside conventional medicine. Recent biological agents have been successful in halting disease progression, however, protracted medication use has also been associated with harmful side effects, including gastrointestinal problems, kidney or liver damage, and cancer. 29 For a group that is expected to actively participate in social, work, and family life for many years to come, long-term behavioral interventions that can be incorporated into the individual's lifestyle are critical. Not only does yoga share many of the benefits of traditional exercise, but yoga is also likely to confer specific benefits such as mindfulness and acceptance of one's pain, as demonstrated by the findings here. Acceptance of pain has been linked to improved physical and emotional functioning in patients with chronic pain, 30 and acceptance-based treatment approaches have gained wide use and approval in pain management. 31 The results of the present study indicate that IY is a potentially valuable treatment tool for promoting young patient's pain acceptance and quality of life. Further research should explore the possibility that yoga's impact upon well-being occurs through pain acceptance.
The lack of group difference on measures of pain and objective disease activity is interesting. It is possible that yoga's main impact is upon a subjective sense of well-being rather than upon biological functioning. Another possibility is that 6 weeks was not a sufficient time-frame to see the kind of fundamental changes that would be required to halt the progression of RA. For example, inflamed joints, included in the DAS28, may require months of strengthening and opening before improvements are evident. Further, the psychological well-being that the yoga group reported may take longer than 6 weeks to feedback into the physiological and structural bodily system to result in reduced inflammation and pain. A longer intervention would be required to ascertain whether biological systems are affected as a result of yoga.
A number of limitations temper the strength of our conclusions. Despite using a standard randomization procedure, it was clear that the groups were different in terms of duration of RA. The yoga group had experienced RA for longer and was more disabled than the control group. In fact, 2 of the participants in the yoga group used wheelchairs, whereas no one in the control group did. Although we controlled for the duration of RA in analyses, it is unlikely that this simple statistical step would have completely accounted for this difference. Although the randomization problems are clearly a study limitation, the fact that we still found group differences favoring the yoga participants speaks to the robustness of IY in improving well-being. We would expect that the control group would remain fairly stable in functioning across the intervention, but they improved over time. It is difficult to know whether spontaneous recovery of functioning was behind this improvement or whether the prospect of undertaking yoga may have sparked improvement. A further limitation is the lack of an active control group; it is not possible to determine whether the benefits seen in the yoga group were a result of the yoga intervention or to nonspecific effects such as group membership. However, there is a lack of consensus in the literature about what constitutes an appropriate active control group in yoga trials and our intention in this early step of the research was to ascertain whether a yoga intervention would be superior to usual care. Another limitation is the sample size. Although the present study is larger than our initial feasibility study, the sample was still relatively small and the findings should be replicated with a larger group of both men and women with RA. The fact that only women entered the study likely speaks to the higher incidence of RA in women 32 and the greater popularity of yoga among women than men. 33 Nevertheless, future studies should actively recruit male patients. Expectations regarding treatment efficacy may also have influenced outcomes (eg, participants were told during class that certain poses were designed to help their symptoms). However, the gradual improvements seen in the weekly reports suggest that benefits were treatment dependent and contingent upon cumulative practice over time.
We must be mindful in differentiating the tradition of yoga employed here, IY, from other forms of yoga practiced within mainstream classes. Yoga is one of the fastest growing activities with 6.1% of the adult US population taking regular classes. 34 However, not all forms of yoga are comparable and there is much variability in teacher training standards, use of supportive props, and knowledge of medical conditions. IY is one of a few traditions that incorporates the kind of training, knowledge, and support that is imperative when studying medical populations. Without a sufficiently trained teacher knowledgeable about RA, patient safety may be compromised. Therefore, we caution against generalizing the study findings to other forms of yoga.
Overall, the findings of this exploratory randomized controlled trial provide promising support for the beneficial effects of IY on young adults with RA. Although the 6-week, twice weekly intervention did not produce significant changes in disease activity or pain, many markers of well-being-including quality of life, mood, and fatigue-improved in the yoga group compared with the control group. Our weekly monitoring data show statistically significant improvement beginning at the second to third week of yoga, and it is possible that improvement would have maintained for as long as participants received yoga. The possibility that participants' functioning would have neared or even reached normative age-related values with long-term practice cannot be ruled out, especially given that their vitality and mental health returned to normative values after only 6 weeks of treatment. Our findings suggest that certain benefits, including improved feelings of general health, may persist long term.
